Abstract
Osthole, an active component of Chinese herbal medicines, reportedly possesses various pharmacological properties and has potential therapeutic applications. This study explored the anti-allergic effects of osthole in asthmatic mice and investigated the immunomodulatory actions of osthole on dendritic cells (DCs) and T cells. Herein, we show that oral administration of osthole to BALB/c mice after ovalbumin (OVA) sensitization ameliorated all of the cardinal features of T helper 2 (Th2)-mediated allergic asthma; namely, the production of OVA-specific immunoglobulin E, airway hyperresponsiveness, airway inflammation and the production of Th2-type cytokines including interleukin (IL)-4, IL-5 and IL-13. Surprisingly, IL-10 production was not inhibited and was even enhanced by osthole treatment. We observed a significant increase in the percentages of IL-10-producing DCs and forkhead box P3-positive regulatory T (Treg) cells in osthole-treated asthmatic mice. Additionally, in vitro analyses revealed that osthole-treated bone-marrow-derived DCs had a partial maturation phenotype, secreting large amounts of IL-10 and low levels of proinflammatory cytokines, such as IL-12, IL-6 and tumor necrosis factor-α, and displaying reduced levels of MHC class II surface molecules. These DCs displayed immunosuppressive capacity by directly inhibiting effector T-cell responses or inducing Treg cells. In addition, osthole directly inhibited the activated CD4+ T-cell proliferation and Th1/Th2-type cytokine production in this system. Collectively, these results suggest that DCs and T cells are potential target cells responsible for the action of osthole against allergic asthma.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Wenzel SE . Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med 2012; 18: 716–725.
Gallelli L, Busceti MT, Vatrella A, Maselli R, Pelaia G . Update on anticytokine treatment for asthma. Biomed Res Int 2013; 2013: 104315.
Lutz MB . Induction of CD4+ regulatory and polarized effector/helper T cells by dendritic cells. Immune Netw 2016; 16: 13–25.
Vroman H, van den Blink B, Kool M . Mode of dendritic cell activation: the decisive hand in Th2/Th17 cell differentiation. Implications in asthma severity? Immunobiology 2015; 220: 254–261.
Galli SJ, Tsai M, Piliponsky AM . The development of allergic inflammation. Nature 2008; 454: 445–454.
Lloyd CM, Saglani S . T cells in asthma: influences of genetics, environment, and T-cell plasticity. J Allergy Clin Immunol 2013; 131: 1267–1274.
Akdis CA . Therapies for allergic inflammation: refining strategies to induce tolerance. Nat Med 2012; 18: 736–749.
Lambrecht BN, Hammad H . Lung dendritic cells in respiratory viral infection and asthma: from protection to immunopathology. Annu Rev Immunol 2012; 30: 243–270.
Ma C, Ma Z, Liao XL, Liu J, Fu Q, Ma S . Immunoregulatory effects of glycyrrhizic acid exerts anti-asthmatic effects via modulation of Th1/Th2 cytokines and enhancement of CD4+CD25+Foxp3+ regulatory T cells in ovalbumin-sensitized mice. J Ethnopharmacol 2013; 148: 755–762.
Gregori S, Passerini L, Roncarolo MG . Clinical outlook for type-1 and FOXP3+ T regulatory cell-based therapy. Front Immunol 2015; 6: 593.
Zeng H, Zhang R, Jin B, Chen L . Type 1 regulatory T cells: a new mechanism of peripheral immune tolerance. Cell Mol Immunol 2015; 12: 566–571.
Noval Rivas M, Chatila TA . Regulatory T cells in allergic diseases. J Allergy Clin Immunol 2016; 138: 639–652.
Cavkaytar O, Akdis CA, Akdis M . Modulation of immune responses by immunotherapy in allergic diseases. Curr Opin Pharmacol 2014; 17: 30–37.
Hartl D, Koller B, Mehlhorn AT, Reinhardt D, Nicolai T, Schendel DJ et al. Quantitative and functional impairment of pulmonary CD4+CD25hi regulatory T cells in pediatric asthma. J Allergy Clin Immunol 2007; 119: 1258–1266.
Provoost S, Maes T, van Durme YM, Gevaert P, Bachert C, Schmidt-Weber CB et al. Decreased FOXP3 protein expression in patients with asthma. Allergy 2009; 64: 1539–1546.
Zhang ZR, Leung WN, Cheung HY, Chan CW . Osthole: a review on its bioactivities, pharmacological properties, and potential as alternative medicine. Evid Based Complement Alternat Med 2015; 2015: 919616.
Chou SY, Hsu CS, Wang KT, Wang MC, Wang CC . Antitumor effects of osthol from Cnidium monnieri: an in vitro and in vivo study. Phytother Res 2007; 21: 226–230.
Chen X, Pi R, Zou Y, Liu M, Ma X, Jiang Y et al. Attenuation of experimental autoimmune encephalomyelitis in C57 BL/6 mice by osthole, a natural coumarin. Eur J Pharmacol 2010; 629: 40–46.
Hua KF, Yang SM, Kao TY, Chang JM, Chen HL, Tsai YJ et al. Osthole mitigates progressive IgA nephropathy by inhibiting reactive oxygen species generation and NF-κB/NLRP3 pathway. PLoS One 2013; 8: e77794.
Matsuda H, Tomohiro N, Ido Y, Kubo M . Anti-allergic effects of cnidii monnieri fructus (dried fruits of Cnidium monnieri and its major component, osthol. Biol Pharm Bull 2002; 25: 809–812.
Liao PC, Chien SC, Ho CL, Wang EI, Lee SC, Kuo YH et al. Osthole regulates inflammatory mediator expression through modulating NF-κB, mitogen-activated protein kinases, protein kinase C, and reactive oxygen species. J Agric Food Chem 2010; 58: 10445–10451.
Okamoto T, Kawasaki T, Hino O . Osthole prevents anti-Fas antibody-induced hepatitis in mice by affecting the caspase-3-mediated apoptotic pathway. Biochem Pharmacol 2003; 65: 677–681.
Chiu PR, Lee WT, Chu YT, Lee MS, Jong YJ, Hung CH . Effect of the Chinese herb extract osthol on IL-4-induced eotaxin expression in BEAS-2B cells. Pediatr Neonatol 2008; 49: 135–140.
Huang HM, Hsiao G, Fan CK, Lin CL, Leu SJ, Chiang BL et al. Notch ligand delta-like 4-pretreated dendritic cells alleviate allergic airway responses by enhancing IL-10 production. PLoS One 2013; 8: e63613.
Pelaia G, Vatrella A, Gallelli L, Renda T, Cazzola M, Maselli R et al. Respiratory infections and asthma. Respir Med 2006; 100: 775–784.
Maynard CL, Weaver CT . Diversity in the contribution of interleukin-10 to T-cell mediated immune regulation. Immunol Rev 2008; 226: 219–233.
Sabat R, Grütz G, Warszawska K, Kirsch S, Witte E, Wolk K et al. Biology of interleukin-10. Cytokine Growth Factor Rev 2010; 21: 331–344.
Duan W, Croft M . Control of regulatory T cells and airway tolerance by lung macrophages and dendritic cells. Ann Am Thorac Soc 2014; 11 (Suppl 5): S306–S313.
Bergqvist A, Andersson CK, Mori M, Walls AF, Bjermer L, Erjefalt JS . Alveolar T-helper type-2 immunity in atopic asthma is associated with poor clinical control. Clin Sci 2015; 128: 47–56.
Geha RS, Jabara HH, Brodeur SR . The regulation of immunoglobulin E class-switch recombination. Nat Rev Immunol 2003; 3: 721–732.
Gould HJ, Sutton BJ . IgE in allergy and asthma today. Nat Rev Immunol 2008; 8: 205–217.
Bagnasco D, Ferrando M, Varricchi G, Passalacqua G, Canonica GW . A critical evaluation of anti-IL-13 and anti-IL-4 strategies in severe asthma. Int Arch Allergy Immunol 2016; 170: 122–131.
Rothenberg ME, Hogan SP . The eosinophil. Annu Rev Immunol 2006; 24: 147–174.
Hawrylowicz CM, O'Garra A . Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma. Nat Rev Immunol 2005; 5: 271–283.
Jin JO, Han X, Yu Q . Interleukin-6 induces the generation of IL-10-producing Tr1 cells and suppresses autoimmune tissue inflammation. J Autoimmun 2013; 40: 28–44.
Lim JY, Im KI, Lee ES, Kim N, Nam YS, Jeon YW et al. Enhanced immunoregulation of mesenchymal stem cells by IL-10-producing type 1 regulatory T cells in collagen-induced arthritis. Sci Rep 2016; 6: 26851.
Lin CL, Hsiao G, Wang CC, Lee YL . Imperatorin exerts antiallergic effects in Th2-mediated allergic asthma via induction of IL-10-producing regulatory T cells by modulating the function of dendritic cells. Pharmacol Res 2016; 110: 111–121.
Koulis A, Robinson DS . The anti-inflammatory effects of interleukin-10 in allergic disease. Clin Exp Allergy 2000; 30: 747–750.
Kearley J, Barker JE, Robinson DS, Lloyd CM . Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+CD25+ regulatory T cells is interleukin-10 dependent. J Exp Med 2005; 202: 1539–1547.
Akdis CA, Akdis M . Mechanisms and treatment of allergic disease in the big picture of regulatory T cells. J Allergy Clin Immunol 2009; 123: 735–746.
Böhm L, Maxeiner J, Meyer-Martin H, Reuter S, Finotto S, Klein M et al. IL-10 and regulatory T cells cooperate in allergen-specific immunotherapy to ameliorate allergic asthma. J Immunol 2015; 194: 887–897.
Resch M, Steigel A, Chen ZL, Bauer R . 5-Lipoxygenase and cyclooxygenase-1 inhibitory active compounds from Atractylodes lancea. J Nat Prod 1998; 61: 347–350.
Li Z, Ji H, Song X, Han N, Chen N . Osthole attenuates the development of carrageenan-induced lung inflammation in rats. Int Immunopharmacol 2014; 20: 33–36.
Roncarolo MG, Gregori S, Bacchetta R, Battaglia M . Tr1 cells and the counter-regulation of immunity: natural mechanisms and therapeutic applications. Curr Top Microbiol Immunol 2014; 380: 39–68.
Ma X, Yan W, Zheng H, Du Q, Zhang L, Ban Y et al. Regulation of IL-10 and IL-12 production and function in macrophages and dendritic cells. F1000Res 2015; 4: F1000 Faculty Rev-1465.
Liu YW, Chen CC, Tseng HP, Chang WC . Lipopolysaccharide-induced transcriptional activation of interleukin-10 is mediated by MAPK- and NF-κB-induced CCAAT/enhancer-binding protein δ in mouse macrophages. Cell Signal 2006; 18: 1492–1500.
Vignali DA, Kuchroo VK . IL-12 family cytokines: immunological playmarkers. Nat Immunol 2012; 13: 722–728.
Li X, Yang A, Huang H, Zhang X, Town J, Davis B et al. Induction of type 2T helper cell allergen tolerance by IL-10-differentiated regulatory dendritic cells. Am J Respir Cell Mol Biol 2010; 42: 190–199.
Volz T, Skabytska Y, Guenova E, Chen KM, Frick JS, Kirschning CJ et al. Nonpathogenic bacteria alleviating atopic dermatitis inflammation induce IL-10-producing dendritic cells and regulatory Tr1 cells. J Invest Dermatol 2014; 134: 96–104.
Acknowledgements
This study was supported by research grants from the Ministry of Science and Technology, Taiwan (MOST 103-2320-B-038-032-MY3) and Wan Fang Hospital, Taipei, Taiwan (104TMU-WFH-14).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information for this article can be found on the Cellular & Molecular Immunology website
Supplementary information
Rights and permissions
About this article
Cite this article
Chiang, CY., Lee, CC., Fan, CK. et al. Osthole treatment ameliorates Th2-mediated allergic asthma and exerts immunomodulatory effects on dendritic cell maturation and function. Cell Mol Immunol 14, 935–947 (2017). https://doi.org/10.1038/cmi.2017.71
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/cmi.2017.71
Keywords
This article is cited by
-
Osthole attenuates asthma-induced airway epithelial cell apoptosis and inflammation by suppressing TSLP/NF-κB-mediated inhibition of Th2 differentiation
Allergy, Asthma & Clinical Immunology (2024)
-
Airborne Bacteria Enriched PM2.5 Enhances the Inflammation in an Allergic Adolescent Mouse Model Induced by Ovalbumin
Inflammation (2020)
-
Notch ligand-expressing adenovirus infection enhances the efficacy of dendritic cell-based immunotherapy for allergic asthma in mice
Cellular & Molecular Immunology (2019)
-
Emodin alleviates alternatively activated macrophage and asthmatic airway inflammation in a murine asthma model
Acta Pharmacologica Sinica (2018)